TP53 and cancer: This assumption was further supported by Amit et al. who demonstrated that the loss of p53 in cancer cells led to neuronal reprogramming and axonogenesis in a mouse model and that the somatic TP53 mutation status was associated with nerve density in a retrospective study with oral cancers [25].